|
|
Volumn 348, Issue 9024, 1996, Pages 404-405
|
|
Cimetidine and immunoreactivity [6]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIMETIDINE;
CYTOKINE;
GAMMA INTERFERON;
HISTAMINE H2 RECEPTOR ANTAGONIST;
INTERLEUKIN 2;
ADULT;
AGED;
CANCER SURVIVAL;
CARDIOPULMONARY BYPASS;
CELLULAR IMMUNITY;
CHROMIUM 51 RELEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLON CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
IMMUNOREACTIVITY;
INTRAVENOUS DRUG ADMINISTRATION;
LETTER;
MALE;
MULTIPLE ORGAN FAILURE;
NATURAL KILLER CELL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUPPRESSOR CELL;
CORONARY ARTERY BYPASS GRAFT;
HEART DISEASE;
HEART VALVE PROSTHESIS;
IMMUNOLOGY;
MIDDLE AGED;
PROSPECTIVE STUDY;
CIMETIDINE;
CORONARY ARTERY BYPASS;
FEMALE;
HEART DISEASES;
HEART VALVE PROSTHESIS;
HUMANS;
IMMUNITY, CELLULAR;
INFUSIONS, INTRAVENOUS;
KILLER CELLS, NATURAL;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
|
|
EID: 0029666152
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)65021-0 Document Type: Letter |
|
Times cited : (17)
|
|
References (5)
|
